I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cleary, Ekaterina Galkina
64
results:
Search for persons
X
Format
Online (64)
Mediatypes
E-Books (2)
Articles (Online) (57)
OpenAccess-fulltext (5)
Sorted by: Relevance
Sorted by: Year
?
1
NIH funding for patents that contribute to market exclusivi..:
Ledley, Fred D.
;
Cleary, Ekaterina Galkina
;
Rake, Bastian
PLOS ONE. 18 (2023) 7 - p. e0288447 , 2023
Link:
https://doi.org/10.1371/..
?
2
Late-stage Product Development and Approvals by Biotechnolo..:
McNamee, Laura M.
;
Cleary, Ekaterina Galkina
;
Zhang, Sunyi
..
Clinical Therapeutics. 43 (2021) 1 - p. 156-171.e15 , 2021
Link:
https://doi.org/10.1016/..
?
3
Comparing long-term value creation after biotech and non-bi..:
Cleary, Ekaterina Galkina
;
McNamee, Laura M.
;
de Boer, Skyler
...
PLOS ONE. 16 (2021) 1 - p. e0243813 , 2021
Link:
https://doi.org/10.1371/..
?
4
NIH funding for vaccine readiness before the COVID-19 pande..:
Kiszewski, Anthony E.
;
Cleary, Ekaterina Galkina
;
Jackson, Matthew J.
.
Vaccine. 39 (2021) 17 - p. 2458-2466 , 2021
Link:
https://doi.org/10.1016/..
?
5
NIH funding for research underlying new cancer therapies:
Cleary, Ekaterina Galkina
;
Ledley, Fred D
The Lancet Oncology. 21 (2020) 6 - p. 755-757 , 2020
Link:
https://doi.org/10.1016/..
?
6
Contribution of NIH funding to new drug approvals 2010–2016:
Cleary, Ekaterina Galkina
;
Beierlein, Jennifer M.
;
Khanuja, Navleen Surjit
..
Proceedings of the National Academy of Sciences of the United States of America. 115 (2018) 10 - p. 2329-2334 , 2018
Link:
https://www.jstor.org/st..
?
7
Making Air Pollution Visible: A Tool for Promoting Environm..:
Cleary, Ekaterina Galkina
;
Patton, Allison P
;
Wu, Hsin-Ching
...
JMIR Public Health and Surveillance. 3 (2017) 2 - p. e16 , 2017
Link:
https://doi.org/10.2196/..
?
8
Contribution of NIH funding to new drug approvals 2010–2016:
Galkina Cleary, Ekaterina
;
Beierlein, Jennifer M.
;
Khanuja, Navleen Surjit
..
Proceedings of the National Academy of Sciences. 115 (2018) 10 - p. 2329-2334 , 2018
Link:
https://doi.org/10.1073/..
?
9
Reference Correction to: Making Air Pollution Visible: A To..:
Galkina Cleary, Ekaterina
;
Patton, Allison P
;
Wu, Hsin-Ching
...
JMIR Public Health and Surveillance. 3 (2017) 4 - p. e80 , 2017
Link:
https://doi.org/10.2196/..
?
10
NIH funding for vaccine readiness before the COVID-19 pande..:
Kiszewski, Anthony
;
Cleary, Ekaterina Galkina
;
Jackson, Matthew
.
https://repository.publisso.de/resource/frl:6429957. , 2021
Link:
https://repository.publi..
?
11
Profitability of Large Pharmaceutical Companies Compared Wi..:
Ledley, Fred D
;
McCoy, Sarah Shonka
;
Vaughan, Gregory
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054843/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
12
Comparison of Research Spending on New Drug Approvals by th..:
Galkina Cleary, Ekaterina
;
Jackson, Matthew J
;
Zhou, Edward W
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148199/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
Comparing long-term value creation after biotech and non-bi..:
Ekaterina Galkina Cleary
;
Laura M McNamee
;
Skyler de Boer
...
https://doi.org/10.1371/journal.pone.0243813. , 2021
Link:
https://doi.org/10.1371/..
?
14
Contribution of NIH funding to new drug approvals 2010–2016:
Galkina Cleary, Ekaterina
;
Beierlein, Jennifer M
;
Khanuja, Navleen Surjit
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878010/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
15
Optimization of the costs of a transport company in the imp..:
Galkina, Ekaterina M.
;
Pochekaeva, Olga V.
;
Zheleznova, Natalya V. Zheleznova
Russian Journal of Water Transport. , 2021
Link:
https://doi.org/10.37890..
1-15